Oxaliplatin Injection, Solution, Concentrate
Product Images NDC 31722-358

This text provides information on DFS probability along with the probability percentages associated with different treatment arms and the hazard ratio between them. It also includes the Stratified Logrank Test result. The data presented here can be used to analyze and compare the efficacy of different treatment options in a clinical setting for DFS (disease-free survival) over time.*

This text is a label for Oxaliplatin Injection, USP, a chemotherapy drug used for intravenous infusion after dilution. It contains important information such as dosage instructions, storage requirements, warning label, and contact details of the manufacturer. It advises not to mix with sodium chloride or chloride-containing solutions and warns that it is a cytotoxic agent. This medication should be stored at room temperature and protected from light. Unused portions should be discarded according to prescribing information. The manufacturer's information and contact details are provided on the label.*

This is a detailed description for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) for intravenous infusion after dilution. The product details include dosage, administration instructions, precautions, handling recommendations, storage conditions, and contact information. It is highlighted as a cytotoxic agent with batch coding for online verification. The injection is a sterile aqueous solution without preservatives, each vial containing Oxaliplatin and Water for Injection, USP. The text emphasizes not mixing with certain solutions and the need for caution due to its cytotoxic nature. The manufacturing information mentions Camber Pharmaceuticals, Inc. and HETERO Labs Limited in India, with relevant licensing details provided.*

This text contains information about a medication called Oxaliplatin Injection, USP in 100 mg/20 (5 mg/ml concentration for intravenous infusion. It comes in a 20 mL single-dose vial and each vial contains oxaliplatin 100 mg and Water for Injection, USP. The storage instructions include keeping it at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F) and protecting it from light. The medication is a cytotoxic agent and should not be mixed with or added to sodium chloride/chloride-containing solutions. It also provides contact information for the manufacturer, Camber Pharmaceuticals, Inc., and important details for batch coding. Further dosage and administration details are advised to be checked in the full prescribing information.*

This prescription details the information for a pharmaceutical product, specifically Oxaliplatin injection. It includes instructions for usage, storage, and handling precautions. The text also mentions batch coding details and manufacturing information for the product. The product is a cytotoxic agent, and caution is advised when handling it. Additionally, it provides a contact number for U.S. inquiries and mentions that the product is manufactured in India.*